The Pharma Data

NOVEMBER 4, 2020

Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on hematology, nephrology, neurology, metabolic disorders, cardiology, ophthalmology and acute care. This press release and further information about Alexion can be found at: www.alexion.com. Forward-Looking Statement.

Antibody 52

Antibody Containment Clinical Trials Clinical Trials 52

The Pharma Data

NOVEMBER 19, 2020

Each patient was given four bottles of statins and four bottles of placebos, each containing identical-looking tablets to be consumed in random order over eight months. He’s interim chief of the division of cardiology and director of the Ahmanson-UCLA Cardiomyopathy Center at the University of California, Los Angeles.

Cardiology 52

Cardiology Drugs Research Containment 52

The Pharma Data

NOVEMBER 16, 2020

The “polypill” containing three generic blood pressure medications and a statin dramatically reduced the risk of heart-related illness in people with no prior history of heart problems, according to clinical trial results. . MONDAY, Nov.

Doctors 52

Doctors Doctor Cardiology Medicine 52

The Pharma Data

OCTOBER 14, 2020

Michael Felker, MD, MHS, FACC, FAHA, FHFSA is Professor of Medicine with tenure in the Division of Cardiology at Duke University School of Medicine. He is Director of Cardiovascular Research at the Duke Clinical Research Institute and Vice-Chief for Clinical Research in the Division of Cardiology. About Dr. Udelson James E.

Cardiology 40

Cardiology Clinical Trials Clinical Trials Medicine 40

The Pharma Data

DECEMBER 12, 2020

It plays a crucial role in many inflammatory and autoimmune diseases across multiple therapy areas, including haematology, nephrology, neurology, metabolic disorders, cardiology, ophthalmology and acute care. The complement cascade is pivotal to the innate immune system. Morgan Stanley & Co. Morgan Cazenove) (“J.P.

Development 75

Development Regulation Medicine Containment 75

The Pharma Data

JANUARY 12, 2021

Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on the core therapeutic areas of hematology, nephrology, neurology, metabolic disorders, cardiology and ophthalmology. This press release and further information about Alexion can be found at: www.alexion.com.

Containment 52

Containment Development Sales Production 52

The Pharma Data

AUGUST 30, 2021

Results were presented at the ESC Congress 2021, organized by the European Society of Cardiology (ESC). This media update contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995. reduction in LDL-C from baseline to Day 510 compared with placebo ( P < 0001) 1.

RNA 52

RNA Trials Production Containment 52

The Pharma Data

AUGUST 29, 2020

Presented at the ESC Congress 2020, the annual meeting of the European Society of Cardiology, the analysis evaluated the efficacy and tolerability of inclisiran on top of a maximally tolerated dose of statins, in two studies of more than 2,300 patients (of which 1,164 were on inclisiran) from the Phase III trials.

Medicine 52

Medicine Containment Trials Production 52

The Pharma Data

OCTOBER 25, 2020

The European Journal of Heart Failure , ASAIO , and the Journal of the American College of Cardiology have published studies that conclude use of ECpella was associated with increased survival rates, as compared to patients who were treated with ECMO only. This press release contains forward-looking statements.

Cardiology 52

Cardiology FDA Approval Development Engineer 52

XTalks

APRIL 15, 2021

Dr. Benoit Tyl, MD, FESC, medical and scientific director, cardiology at Servier, says that the disconnect between correlation and causality in cardiovascular disease trials is partially responsible for the lack of approved HFpEF therapies. However, these drugs have shown limited effectiveness in treating HFpEF.

Development 98

Development Drugs Genome Genomics 98

XTalks

JANUARY 19, 2024

Radiobiological and Clinical Considerations from CRO and Emerging Biotech Radiopharmaceuticals are medicinal formulations containing radioisotopes that are used in the field of nuclear medicine primarily for the diagnosis and treatment of various diseases, particularly cancer. In addition, the cascades can also contain beta emissions.

DNA 66

DNA Radiology FDA Approval Development 66

XTalks

AUGUST 2, 2023

It contains the antiviral medications nirmatrelvir and ritonavir. It works by containing lymphocytes within the lymph nodes , preventing them from entering the central nervous system via the blood-brain barrier and causing an autoimmune reaction that destroys myelin on neurons. Pfizer’s total global revenue from Paxlovid was $18.93

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

SEPTEMBER 15, 2020

The team shared results from a Phase 2a study that was conducted by Akcea Therapeutics/Ionis Pharmaceuticals and previously disclosed at the recent European Society of Cardiology Congress 2020. Disclosure Notice: The information contained in this release is as of September 15, 2020. and -50.4%

Gene Therapy 52

Gene Therapy Vaccine Vaccination Trials 52

XTalks

FEBRUARY 8, 2024

According to AstraZeneca, the drug had strong demand across all of its approved indications and was further supported by recent guideline updates from cardiology societies. for a pack of three pens, each containing 1.5 This performance exceeded Wall Street’s expectations by 20 percent. mL of 300 units/mL.

Sales 52

Sales Insulin FDA Approval Drugs 52

The Pharma Data

NOVEMBER 4, 2020

Expanded m edical society recommendations in support of the efficacy and safety of VASCEPA : The European Society of Cardiology expanded their guidelines to recommend use of VASCEPA in treating acute coronary syndrome patients. The design of the REDUCE-IT study was published in March 2017 in Clinical Cardiology.

Sales 40

Sales Production Marketing Cardiology 40

The Pharma Data

APRIL 26, 2021

Topline results will be presented at the American College of Cardiology 70th Annual Scientific Session. The safety profile of Entresto was confirmed. Novartis will continue to evaluate the data.

Sales 40

Sales Medicine Production Manufacturing 40

The Pharma Data

OCTOBER 29, 2020

Alexion focuses its research efforts on novel molecules and targets in the complement cascade and its development efforts on hematology, nephrology, neurology, metabolic disorders, cardiology, ophthalmology and acute care. This press release and further information about Alexion can be found at: www.alexion.com. Forward-Looking Statement.

Sales 40

Sales Clinical Trials Clinical Trials Production 40

The Pharma Data

MAY 13, 2021

Fructose Containing Sugars at Normal Levels of Consumption Do Not Effect Adversely Components of the Metabolic Syndrome and Risk Factors for Cardiovascular Disease. Fructose-containing sugars, blood pressure, and cardiometabolic risk: a critical review. Journal of the American College of Cardiology. Arq Gastroenterol.

Insulin 52

Insulin Production Hormones Medicine 52

Pharmaceutical Technology

MAY 26, 2023

John Hertig, the president of the board of directors for the nonprofit Alliance for Safe Online Pharmacies (ASOP) Global says, “Counterfeit products sold by illegal online pharmacies often are manufactured in unsafe conditions, contain little or no active ingredients and/or are manufactured using dangerous and sometimes deadly substances.”

Pharmacy 130

Pharmacy Regulation Drugs Insulin 130